Filing Details

Accession Number:
0001566028-13-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-01 12:42:17
Reporting Period:
2013-09-27
Filing Date:
2013-10-01
Accepted Time:
2013-10-01 12:42:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887497 Hi Tech Pharmacal Co Inc HITK Pharmaceutical Preparations (2834) 112638720
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1186837 M Martin Goldwyn C/O Tashlik Kreutzer Goldwyn &Amp; Crandell
40 Cuttermill Road
Great Neck NY 11021
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-27 4,308 $13.50 4,308 No 4 M Direct
Common Stock Disposition 2013-09-27 4,308 $0.00 0 No 4 J Direct
Common Stock Acquisiton 2013-09-27 3,000 $24.95 3,000 No 4 M Direct
Common Stock Disposition 2013-09-27 3,000 $43.10 0 No 4 S Direct
Common Stock Acquisiton 2013-09-30 3,111 $13.50 3,111 No 4 M Direct
Common Stock Disposition 2013-09-30 3,111 $0.00 0 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 J Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 J Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-09-27 4,308 $0.00 4,308 $13.50
Common Stock Stock Option (Right to Buy) Disposition 2013-09-27 3,000 $0.00 3,000 $24.95
Common Stock Stock Option (Right to Buy) Disposition 2013-09-30 3,111 $0.00 3,111 $13.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,111 2004-11-28 2013-11-28 No 4 M Direct
9,375 2006-11-08 2015-11-08 No 4 M Direct
0 2004-11-28 2013-11-28 No 4 M Direct
Footnotes
  1. The shares acquired upon exercise of the options reflected on this form were immediately distributed without consideration to a partner or partners in Mr. Goldwyn's law firm.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.07 to $43.15, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4.
  3. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
  4. The option became exercisable in four equal annual installments beginning on the first anniversary of the grant date.
  5. Other than the option to acquire an additional 9,375 shares of the Company's stock reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 75,400 shares of the Company's stock (for options to acquire an aggregate of 84,775 shares). The other options were granted on various dates, with varying exercise prices and exercisable and expiration dates.